本页面由Tiger Trade Technology Pte. Ltd.提供服务

Prelude Therapeutics Inc

3.26
+0.14004.49%
盘前3.390.1300+3.99%08:00 EDT
成交量:9.98万
成交额:32.67万
市值:2.05亿
市盈率:-2.52
高:3.40
开:3.15
低:3.15
收:3.12
52周最高:4.22
52周最低:0.6101
股本:6,286.53万
流通股本:250.24万
量比:0.50
换手率:3.99%
股息:- -
股息率:- -
每股收益(TTM):-1.2929
每股收益(LYR):-1.2929
净资产收益率:-99.45%
总资产收益率:-40.74%
市净率:2.99
市盈率(LYR):-2.52

数据加载中...

2024/02/16

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/11

重要事件披露

Form 8-K - Current report
2023/11/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/01

重要事件披露

Form 8-K - Current report
2023/08/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/03

重要事件披露

Form 8-K - Current report
2023/06/22

重要事件披露

Form 8-K - Current report
2023/06/02

重要事件披露

Form 8-K - Current report
2023/05/24

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/24

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/20

重要事件披露

Form 8-K - Current report
2023/05/18

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/05/17

重要事件披露

Form 8-K - Current report
2023/05/08

重要事件披露

8-K - Current report